| Literature DB >> 22478784 |
Abstract
Risk sharing is an old idea that has taken many forms in the era of managed care. But with the emergence of high-cost biopharmaceuticals, payers and purchasers are keen on a new twist: putting the onus on manufacturers to prove that their products are as good as advertised. Popular in Europe, risk-sharing contracts are gaining traction in the United States.Year: 2009 PMID: 22478784 PMCID: PMC2799096
Source DB: PubMed Journal: Biotechnol Healthc ISSN: 1554-169X